The ISMA delegation to the AMA advanced seven resolutions for consideration at the AMA House of Delegates Annual Meeting in June, with two measures ultimately adopted as amended and incorporated into AMA policy.
ISMA submitted 2025 House of Delegates Resolutions 25-23, 25-32, 25-36, 25-40, 25-42, 25-49 and 25-62 for consideration by the AMA House of Delegates. Of those measures, Resolutions 25-49 and 25-62 were adopted as amended following review by AMA reference committees and debate before the AMA House of Delegates.
Addressing physician impersonation
Resolution 25-49, introduced by
Tracey Wilkinson, MD, and
Daniel Udrea, MD, sought to address the growing threat of physician impersonation.
The policy reflects growing concerns about fraudulent representation of physicians in both clinical and digital settings and establishes AMA support for stronger legal and regulatory safeguards.
The resolution was considered by the AMA House of Delegates as Resolution 005 and was assigned to the Reference Committee on Ethics and Bylaws. Following committee review and testimony, the House of Delegates adopted the measure as amended.
The adopted AMA policy:
- Recognizes physician impersonation as a significant threat to public health and patient safety.
- Supports the creation and enforcement of state laws prohibiting physician impersonation.
- Encourages the development of clear public reporting mechanisms and collaboration among medical boards, law enforcement and legislative bodies to ensure accurate identification and documentation of physician impersonation and appropriate consequences.
- Promotes improved coordination among regulatory bodies to prevent and address impersonation of licensed physicians.
Supporting privacy protections for AI scribes
Resolution 25-62, introduced by
Apoorva Tummala, MD, Dr. Udrea and
Madi McDole, DO, focused on privacy concerns related to the increasing use of artificial intelligence-powered medical scribe technologies.
The policy highlights physician concerns regarding the collection, storage and use of sensitive patient and clinician data by AI-enabled documentation tools and signals AMA support for federal oversight in this rapidly evolving area.
The resolution was considered by the AMA House of Delegates as Resolution 007 and was also assigned to the Reference Committee on Ethics and Bylaws.
After consideration by the committee and the House of Delegates, the resolution was adopted as amended, as follows.
"That our American Medical Association pursue federal regulation of artificial intelligence (AI) scribe technologies that protects clinician and patient privacy."
Delegation advocacy
The adoption of the two measures represents policy successes for Indiana physicians and the ISMA delegation. Both resolutions address emerging issues affecting patient safety, physician practice and public trust in health care.
As of publication, the AMA has not yet assigned PolicyFinder identification numbers to the newly adopted policies. Additional information, including the
final annotated reports from the Reference Committee on Ethics and Bylaws, is available to AMA members through the
AMA meeting materials online.

ISMA Vice Speaker and AMA Alternate Delegate Tashera Perry, MD, testifies
during the House of Delegates at the AMA Annual Meeting.